vs
AMREP CORP.（AXR）与Foghorn Therapeutics Inc.（FHTX）财务数据对比。点击上方公司名可切换其他公司
AMREP CORP.的季度营收约是Foghorn Therapeutics Inc.的1.6倍（$14.6M vs $9.2M），AMREP CORP.净利率更高（21.6% vs -234.3%，领先255.9%），Foghorn Therapeutics Inc.同比增速更快（223.8% vs 93.8%），过去两年Foghorn Therapeutics Inc.的营收复合增速更高（35.3% vs -13.6%）
AMREP是一家总部位于美国新泽西州普林斯顿的企业，核心业务涵盖房地产与媒体服务领域。公司前身为美国地产石油公司，于1961年正式成立，在相关行业拥有六十余年的发展运营历史。
Foghorn Therapeutics是一家临床阶段生物技术企业，专注于开发靶向染色质调控系统的创新疗法，用于治疗多种癌症及其他严重疾病，目前推进多款靶向候选药物管线，通过自主研发与战略合作服务全球患者群体。
AXR vs FHTX — 直观对比
营收规模更大
AXR
是对方的1.6倍
$9.2M
营收增速更快
FHTX
高出130.0%
93.8%
净利率更高
AXR
高出255.9%
-234.3%
两年增速更快
FHTX
近两年复合增速
-13.6%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $14.6M | $9.2M |
| 净利润 | $3.1M | $-21.7M |
| 毛利率 | — | — |
| 营业利润率 | 20.6% | -258.2% |
| 净利率 | 21.6% | -234.3% |
| 营收同比 | 93.8% | 223.8% |
| 净利润同比 | 338.9% | -11.1% |
| 每股收益（稀释后） | $0.58 | $-0.35 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXRFHTX
| Q1 26 | $14.6M | — | ||
| Q4 25 | $9.4M | $9.2M | ||
| Q3 25 | $17.9M | $8.2M | ||
| Q2 25 | $11.2M | $7.6M | ||
| Q1 25 | $7.5M | $6.0M | ||
| Q4 24 | $11.9M | $2.9M | ||
| Q3 24 | $19.1M | $7.8M | ||
| Q2 24 | $19.5M | $6.9M |
净利润AXRFHTX
| Q1 26 | $3.1M | — | ||
| Q4 25 | $1.2M | $-21.7M | ||
| Q3 25 | $4.7M | $-15.8M | ||
| Q2 25 | $3.9M | $-17.9M | ||
| Q1 25 | $717.0K | $-18.8M | ||
| Q4 24 | $4.0M | $-19.5M | ||
| Q3 24 | $4.1M | $-19.1M | ||
| Q2 24 | $4.1M | $-23.0M |
营业利润率AXRFHTX
| Q1 26 | 20.6% | — | ||
| Q4 25 | 11.9% | -258.2% | ||
| Q3 25 | 34.4% | -226.9% | ||
| Q2 25 | 31.7% | -279.2% | ||
| Q1 25 | 5.7% | -385.0% | ||
| Q4 24 | 26.4% | -840.5% | ||
| Q3 24 | 26.1% | -305.5% | ||
| Q2 24 | 23.9% | -386.6% |
净利率AXRFHTX
| Q1 26 | 21.6% | — | ||
| Q4 25 | 12.8% | -234.3% | ||
| Q3 25 | 26.3% | -194.4% | ||
| Q2 25 | 34.8% | -237.3% | ||
| Q1 25 | 9.5% | -316.4% | ||
| Q4 24 | 33.9% | -682.9% | ||
| Q3 24 | 21.3% | -244.9% | ||
| Q2 24 | 21.2% | -333.6% |
每股收益（稀释后）AXRFHTX
| Q1 26 | $0.58 | — | ||
| Q4 25 | $0.22 | $-0.35 | ||
| Q3 25 | $0.87 | $-0.25 | ||
| Q2 25 | $0.73 | $-0.28 | ||
| Q1 25 | $0.13 | $-0.30 | ||
| Q4 24 | $0.75 | $-0.23 | ||
| Q3 24 | $0.76 | $-0.31 | ||
| Q2 24 | $0.77 | $-0.45 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $50.0M | $80.9M |
| 总债务越低越好 | $21.0K | — |
| 股东权益账面价值 | $139.4M | $-108.5M |
| 总资产 | $143.9M | $198.1M |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势，按日历期对齐
现金及短期投资AXRFHTX
| Q1 26 | $50.0M | — | ||
| Q4 25 | $44.6M | $80.9M | ||
| Q3 25 | $48.9M | $89.3M | ||
| Q2 25 | $39.5M | $72.6M | ||
| Q1 25 | $36.9M | $61.0M | ||
| Q4 24 | $40.1M | $55.5M | ||
| Q3 24 | $40.4M | $57.7M | ||
| Q2 24 | $29.7M | $138.9M |
总债务AXRFHTX
| Q1 26 | $21.0K | — | ||
| Q4 25 | $23.0K | — | ||
| Q3 25 | $25.0K | — | ||
| Q2 25 | $26.0K | — | ||
| Q1 25 | $29.0K | — | ||
| Q4 24 | $32.0K | — | ||
| Q3 24 | $34.0K | — | ||
| Q2 24 | $35.0K | — |
股东权益AXRFHTX
| Q1 26 | $139.4M | — | ||
| Q4 25 | $136.0M | $-108.5M | ||
| Q3 25 | $134.7M | $-89.7M | ||
| Q2 25 | $130.0M | $-76.7M | ||
| Q1 25 | $126.0M | $-61.7M | ||
| Q4 24 | $125.1M | $-45.5M | ||
| Q3 24 | $122.2M | $-28.3M | ||
| Q2 24 | $118.0M | $-14.3M |
总资产AXRFHTX
| Q1 26 | $143.9M | — | ||
| Q4 25 | $140.1M | $198.1M | ||
| Q3 25 | $140.7M | $205.0M | ||
| Q2 25 | $133.8M | $226.2M | ||
| Q1 25 | $128.9M | $258.7M | ||
| Q4 24 | $129.1M | $284.0M | ||
| Q3 24 | $127.0M | $308.4M | ||
| Q2 24 | $122.8M | $328.6M |
负债/权益比AXRFHTX
| Q1 26 | 0.00× | — | ||
| Q4 25 | 0.00× | — | ||
| Q3 25 | 0.00× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — | ||
| Q4 24 | 0.00× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $5.4M | $-22.3M |
| 自由现金流经营现金流 - 资本支出 | $5.4M | — |
| 自由现金流率自由现金流/营收 | 37.0% | — |
| 资本支出强度资本支出/营收 | 0.1% | 0.0% |
| 现金转化率经营现金流/净利润 | 1.72× | — |
| 过去12个月自由现金流最近4个季度 | $20.2M | — |
8季度趋势，按日历期对齐
经营现金流AXRFHTX
| Q1 26 | $5.4M | — | ||
| Q4 25 | $-4.3M | $-22.3M | ||
| Q3 25 | $9.5M | $-18.9M | ||
| Q2 25 | $10.2M | $-21.0M | ||
| Q1 25 | $-3.2M | $-24.0M | ||
| Q4 24 | $-182.0K | $-24.5M | ||
| Q3 24 | $10.7M | $-21.0M | ||
| Q2 24 | $10.7M | $-25.5M |
自由现金流AXRFHTX
| Q1 26 | $5.4M | — | ||
| Q4 25 | $-4.3M | — | ||
| Q3 25 | $9.5M | — | ||
| Q2 25 | $9.7M | $-21.0M | ||
| Q1 25 | $-3.3M | $-24.0M | ||
| Q4 24 | $-268.0K | $-25.0M | ||
| Q3 24 | $10.7M | $-21.3M | ||
| Q2 24 | $10.3M | $-25.6M |
自由现金流率AXRFHTX
| Q1 26 | 37.0% | — | ||
| Q4 25 | -45.9% | — | ||
| Q3 25 | 53.2% | — | ||
| Q2 25 | 86.4% | -278.2% | ||
| Q1 25 | -43.4% | -403.2% | ||
| Q4 24 | -2.3% | -875.3% | ||
| Q3 24 | 55.8% | -273.0% | ||
| Q2 24 | 52.5% | -371.0% |
资本支出强度AXRFHTX
| Q1 26 | 0.1% | — | ||
| Q4 25 | 0.6% | 0.0% | ||
| Q3 25 | 0.1% | 0.0% | ||
| Q2 25 | 5.2% | 0.3% | ||
| Q1 25 | 0.3% | 0.5% | ||
| Q4 24 | 0.7% | 16.8% | ||
| Q3 24 | 0.2% | 4.0% | ||
| Q2 24 | 2.3% | 0.2% |
现金转化率AXRFHTX
| Q1 26 | 1.72× | — | ||
| Q4 25 | -3.54× | — | ||
| Q3 25 | 2.03× | — | ||
| Q2 25 | 2.63× | — | ||
| Q1 25 | -4.51× | — | ||
| Q4 24 | -0.05× | — | ||
| Q3 24 | 2.63× | — | ||
| Q2 24 | 2.59× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
